DelMar Pharmaceuticals, Inc.·4

Apr 3, 4:07 PM ET

Mohr Erich 4

4 · DelMar Pharmaceuticals, Inc. · Filed Apr 3, 2018

Insider Transaction Report

Form 4
Period: 2018-03-30
Mohr Erich
Director
Transactions
  • Other

    Common Stock

    2018-03-30$3.20/sh+528$1,6908,222 total
Footnotes (1)
  • [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock

Documents

1 file
  • 4
    f4033018mohr_delmar.xmlPrimary

    OWNERSHIP DOCUMENT